Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+13.58%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$286M
Cap. Flow %
-1.68%
Top 10 Hldgs %
33.75%
Holding
1,485
New
138
Increased
706
Reduced
317
Closed
71

Sector Composition

1 Real Estate 60.4%
2 Technology 9.5%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.46%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRBU icon
1201
Caribou Biosciences
CRBU
$174M
$3K ﹤0.01%
+176
New +$3K
DAWN icon
1202
Day One Biopharmaceuticals
DAWN
$773M
$3K ﹤0.01%
+181
New +$3K
DSGN icon
1203
Design Therapeutics
DSGN
$367M
$3K ﹤0.01%
+162
New +$3K
GLUE icon
1204
Monte Rosa Therapeutics
GLUE
$305M
$3K ﹤0.01%
+136
New +$3K
GOSS icon
1205
Gossamer Bio
GOSS
$668M
$3K ﹤0.01%
260
IDYA icon
1206
IDEAYA Biosciences
IDYA
$2.38B
$3K ﹤0.01%
132
IGMS
1207
DELISTED
IGM Biosciences
IGMS
$3K ﹤0.01%
88
IMVT icon
1208
Immunovant
IMVT
$2.99B
$3K ﹤0.01%
394
INVA icon
1209
Innoviva
INVA
$1.29B
$3K ﹤0.01%
191
IPSC icon
1210
Century Therapeutics
IPSC
$43.6M
$3K ﹤0.01%
+159
New +$3K
KURA icon
1211
Kura Oncology
KURA
$713M
$3K ﹤0.01%
227
MCRB icon
1212
Seres Therapeutics
MCRB
$169M
$3K ﹤0.01%
16
MGNX icon
1213
MacroGenics
MGNX
$126M
$3K ﹤0.01%
209
MGTX icon
1214
MeiraGTx Holdings
MGTX
$619M
$3K ﹤0.01%
130
+48
+59% +$1.11K
MXCT icon
1215
MaxCyte
MXCT
$150M
$3K ﹤0.01%
+293
New +$3K
PGEN icon
1216
Precigen
PGEN
$1.3B
$3K ﹤0.01%
708
PMVP icon
1217
PMV Pharmaceuticals
PMVP
$77.4M
$3K ﹤0.01%
+132
New +$3K
PRAX icon
1218
Praxis Precision Medicines
PRAX
$986M
$3K ﹤0.01%
+9
New +$3K
QSI icon
1219
Quantum-Si Incorporated
QSI
$219M
$3K ﹤0.01%
+343
New +$3K
QURE icon
1220
uniQure
QURE
$985M
$3K ﹤0.01%
158
RPTX icon
1221
Repare Therapeutics
RPTX
$72.6M
$3K ﹤0.01%
127
SRRK icon
1222
Scholar Rock
SRRK
$3.02B
$3K ﹤0.01%
118
STOK icon
1223
Stoke Therapeutics
STOK
$1.13B
$3K ﹤0.01%
126
VNDA icon
1224
Vanda Pharmaceuticals
VNDA
$272M
$3K ﹤0.01%
191
KLRS
1225
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
$3K ﹤0.01%
10